Serratiopeptidase is refer as a proteolytic enzyme which is been obtained from the silkworm. It is basically used to reduce pain and swelling associated with conditions like back pain, tension headaches, arthritis and migraine headaches, also including sinusitis, laryngitis, ear infections, sore throat, swelling after surgery, also swelling of a vein with the formation of a blood clot that is thrombophlebitis, and inflammatory bowel disease (IBD) which includes Crohn's disease. and ulcerative colitis. However, there are some lacking in the clinical evidence which are supporting the use of this medicine for such conditions. Some of the other name use for serratiopeptidase are Enzyme de Ver de Soie, Butterfly Enzyme, Extrait de Ver de Soie, SER, Serrapeptidase, Serratia peptidase, Silk Worm Enzyme, Serrapeptase, Silkworm Extract.According to AMA, the market for serratiopeptidase is expected to register a CAGR of 5.27% during the forecast period to 2026. This growth is primarily driven by Increasing geriatric population.
Globally, a noticeable market trend is evident Rising awareness related to personal healthcare
. Major Players, such as M/S Advanced Enzyme Technologies Ltd (India), Biocon (India), Krebs Biochemicals & Industries Ltd. (India), Fermenta Biotech Ltd (India), UNIQUE BIOTECH LIMITED (India), Beijing Geyuantianrun Bio-Tech Co, Ltd (China), Newgen Biotech Inc (United States), Vaishali Pharma Ltd (India) and Enzymedica, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
LGM Pharma LLC completed the acquisition of Zeta Pharmaceuticals’ compounding business. The acquisition of Zeta’s compounding business is a part of LGM’s strategy to invest in expanding its market presence and capabilities in an effort to better serve the pharmaceutical industry with a broad range of API and complementary services
- Increasing geriatric population
- Rising awareness related to personal healthcare
- Growing camps associated with the health knowledge
- Side effects associated with the intake of serratiopeptidase
Growth potential offered by emerging countries
The high cost associated with the products
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, serratiopeptidase Study Sheds Light on
— The serratiopeptidase Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the serratiopeptidase industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where serratiopeptidase industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.